MTD vs TVRD · P/E 27, rev $1.97B vs rev $2.6M
Mettler-Toledo International Inc (MTD) versus Tvardi Therapeutics, Inc. (TVRD) — a side-by-side from cached financials, not a winner call.
Mettler-Toledo International Inc (MTD) is a diagnostics & research company listed on NYSE.
Tvardi Therapeutics, Inc. (TVRD) is a biotechnology company listed on US.
Latest reported MTD revenue for 2026-06-30 was $1.97B. Net income was $402.4M. MTD currently screens at market cap $23.20B and trailing P/E 26.9.
Latest reported TVRD revenue for 2025-03-31 was $2.6M. Net income was -$4.9M. TVRD currently screens at market cap $0.
MTD currently screens at market cap $23.20B and trailing P/E 26.9. TVRD currently screens at market cap $0.
Not investment advice. Open the MTD and TVRD stock pages for the full models.
Not investment advice.